SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001662252-18-000076
Filing Date
2018-07-17
Accepted
2018-07-17 16:13:29
Documents
67
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-K rcha10k.htm 10-K 886375
2 EX-3.11 ex3_11.htm EX-3.11 311189
3 EX-3.12 ex3_12.htm EX-3.12 34037
4 EX-3.13 ex3_13.htm EX-3.13 127959
5 EX-10.73 ex10_73.htm EX-10.73 197191
6 EX-31 ex31.htm EX-31 10205
7 EX-32 ex32.htm EX-32 3684
8 GRAPHIC image_001.gif GRAPHIC 2222
9 GRAPHIC image_002.gif GRAPHIC 4897
10 GRAPHIC image_001.jpg GRAPHIC 18763
  Complete submission text file 0001662252-18-000076.txt   5221041

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE FILE rcha-20180331.xml EX-101.INS 734540
12 XBRL SCHEMA FILE rcha-20180331.xsd EX-101.SCH 67390
13 XBRL CALCULATION FILE rcha-20180331_cal.xml EX-101.CAL 38199
14 XBRL DEFINITION FILE rcha-20180331_def.xml EX-101.DEF 181146
15 XBRL LABEL FILE rcha-20180331_lab.xml EX-101.LAB 294479
16 XBRL PRESENTATION FILE rcha-20180331_pre.xml EX-101.PRE 275376
Mailing Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212
Business Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212 (424) 230-7001
Rich Pharmaceuticals, Inc. (Filer) CIK: 0001504389 (see all company filings)

IRS No.: 463259117 | State of Incorp.: WY | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 000-54767 | Film No.: 18956642
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1